• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DFAN14A filed by Enhabit Inc.

    6/17/24 4:47:50 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    DFAN14A 1 dfan14a12397015_06172024.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

    (Rule 14a-101)

     

    INFORMATION REQUIRED IN PROXY STATEMENT

     

    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

     

    (Amendment No. )

     

    Filed by the Registrant ☐

     

    Filed by a Party other than the Registrant ☒

     

    Check the appropriate box:

     

    ☐Preliminary Proxy Statement

     

    ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐Definitive Proxy Statement

     

    ☒Definitive Additional Materials

     

    ☐Soliciting Material Under § 240.14a-12

      

    ENHABIT, INC.

    (Name of Registrant as Specified In Its Charter)

     

    AREX CAPITAL MASTER FUND, LP

    AREX CAPITAL PARTNERS, LP

    AREX CAPITAL, LTD.

    AREX CAPITAL GP, LLC

    AREX CAPITAL MANAGEMENT, LP

    AREX CAPITAL MANAGEMENT GP, LLC

    ANDREW RECHTSCHAFFEN

    JAMES T. CORCORAN

    MEGAN AMBERS

    MAXINE HOCHHAUSER

    MARK W. OHLENDORF

    ANNA-GENE O’NEAL

    DR. GREGORY S. SHEFF

    JUAN VALLARINO

    (Name of Persons(s) Filing Proxy Statement, if other than the Registrant)

     

     

     

    Payment of Filing Fee (Check all boxes that apply):

     

    ☒No fee required

     

    ☐Fee paid previously with preliminary materials

      

    ☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

    AREX Capital Master Fund, LP, an exempted limited partnership organized under the laws of the Cayman Islands, together with the other participants named herein (collectively, “AREX”), has filed a definitive proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the election of its slate of highly-qualified director nominees at the 2024 annual meeting of stockholders (the “Annual Meeting”) of Enhabit, Inc., a Delaware corporation (the “Company”).

    Item 1: On June 17, 2024, AREX issued an open letter to its fellow stockholders titled, “AREX Sets the Record Straight”, a copy of which is attached hereto as Exhibit 1 and incorporated herein by reference.

    Item 2: On June 17, 2024, AREX Capital Master issued the following press release:

    AREX CAPITAL SETS THE RECORD STRAIGHT REGARDING ENHABIT’S MISLEADING ASSERTIONS

    Reiterates Need for Boardroom Change This Year Following Enhabit’s Staggering Operating and Financial Underperformance

    Believes Enhabit’s Stockholders Deserve Leadership That Can Navigate Challenging External Environment

    Disappointed by Board’s Continued Refusal to Engage

    Urges Stockholders to Vote FOR the AREX Nominees—Who are Best Positioned to Rehabilitate Enhabit—on the WHITE Proxy Card

    New York (June 17, 2024) — AREX Capital Management, LP (together with its affiliates, “AREX” or “we”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit”), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit’s recent communications.

    The full text of the letter can be found here: AREX Sets the Record Straight.1

    We believe voting for all seven of AREX’s nominees on the WHITE proxy card at the upcoming 2024 Annual Meeting of Stockholders is the best way to ensure that Enhabit can remain a leader in the home health and hospice industries with a Board that is capable of effective management oversight and is accountable to stockholders.

    Stockholders are encouraged to visit www.rehabEHAB.com for additional information.

    About AREX

    AREX Capital Management, LP is a value-oriented investment firm based in New York City. AREX takes a long-term, opportunistic approach to investing and focuses primarily on publicly traded companies with significant, unrealized potential.


    1 https://www.rehabehab.com/_files/ugd/4b2160_4ab041adcfc9414fb3250bc93918baea.pdf

     

     

    Investor Contact

    Saratoga Proxy Consulting
    John Ferguson
    (212) 257-1311
    [email protected]

    Media Contact

    Longacre Square Partners
    Greg Marose / Charlotte Kiaie
    (646) 386-0091
    [email protected]

     

    Item 3: AREX posted the following material to www.rehabehab.com: 

    A close-up of a document

Description automatically generated

     

    A close-up of a press release

Description automatically generated

     

     

    A screenshot of a computer

Description automatically generated

     

    A close-up of a letter

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

    A screenshot of a computer

Description automatically generated

     

    A close-up of a letter

Description automatically generated

     

    Close-up of a document

Description automatically generated

     

    A screenshot of a website

Description automatically generated

     

    Close-up of a letter

Description automatically generated

     

    A close-up of a document

Description automatically generated

     

     

    Get the next $EHAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    1/22/2026$14.00Perform → Outperform
    Oppenheimer
    1/13/2026$12.00Hold → Buy
    TD Cowen
    1/8/2026$12.00Neutral → Buy
    UBS
    1/7/2026$10.50Hold
    Truist
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    More analyst ratings

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enhabit Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Enhabit Inc. from Perform to Outperform and set a new price target of $14.00

    1/22/26 8:46:17 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by TD Cowen with a new price target

    TD Cowen upgraded Enhabit Inc. from Hold to Buy and set a new price target of $12.00

    1/13/26 8:41:29 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by UBS with a new price target

    UBS upgraded Enhabit Inc. from Neutral to Buy and set a new price target of $12.00

    1/8/26 8:09:53 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enhabit Announces Participation in Bank of America Home Care Conference 2025

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced its participation in the Bank of America Home Care Conference 2025. Enhabit's President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Dec. 9, at 2:50 p.m. CT. The fireside chat will be webcast live at https://bofa.veracast.com/webcasts/bofa/homecare2025/M4EufU.cfm, and a replay will be available at the same URL within 24 hours after the event's conclusion. Both the live webcast and replay will also be accessible on Enhabit's investor website under "Events & Presentations." About Enhabit Home Health & Hospice Enhabit Home Healt

    12/2/25 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Reports Third Quarter 2025 Financial Results

    Company to host a conference call tomorrow, November 6, 2025, at 9:00 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. "Our third quarter results reflect strong execution on our core strategic priorities, with year-over-year growth in revenue, census and Adjusted EBITDA," said Barb Jacobsmeyer, president and CEO of Enhabit. "This progress allowed us to further reduce our bank debt and strengthen the balance sheet during the quarter." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $263.6 million Net income attributable to Enhabit, Inc. of $11.1 million

    11/5/25 4:13:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Announces Participation in UBS Global Healthcare Conference 2025

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced its participation in the UBS Global Healthcare Conference 2025. Enhabit's President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Nov. 11 at 11:30 a.m. CT. The fireside chat will be webcast live and available for replay on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they

    10/28/25 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    SEC Filings

    View All

    Enhabit Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Enhabit, Inc. (0001803737) (Filer)

    12/9/25 7:02:24 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Enhabit Inc.

    10-Q - Enhabit, Inc. (0001803737) (Filer)

    11/5/25 4:24:42 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Enhabit, Inc. (0001803737) (Filer)

    11/5/25 4:17:59 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Solomon Ryan bought $76,400 worth of shares (10,000 units at $7.64), increasing direct ownership by 5% to 193,468 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    8/11/25 6:30:04 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/12/24 5:01:19 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/11/24 5:56:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schochet Barry P. was granted 2,382 shares, increasing direct ownership by 4% to 70,232 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    1/12/26 8:51:15 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Rodgers Stephan was granted 1,881 shares, increasing direct ownership by 10% to 19,998 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    1/12/26 8:50:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Ohlendorf Mark W was granted 1,881 shares, increasing direct ownership by 4% to 44,527 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    1/12/26 8:49:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Enhabit Inc.

    SC 13G - Enhabit, Inc. (0001803737) (Subject)

    11/14/24 9:12:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Enhabit Inc.

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    10/4/24 1:56:05 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    2/13/24 5:04:31 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Leadership Updates

    Live Leadership Updates

    View All

    Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

    On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court

    12/4/24 8:30:00 AM ET
    $EHAB
    $EHC
    Medical/Nursing Services
    Health Care
    Hospital/Nursing Management

    Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

    Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl

    11/7/24 7:30:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    American Water Appoints New Independent Member to the Board of Directors

    American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan

    10/30/24 4:46:00 PM ET
    $AWK
    $EHAB
    Water Supply
    Utilities
    Medical/Nursing Services
    Health Care

    $EHAB
    Financials

    Live finance-specific insights

    View All

    Enhabit Reports Third Quarter 2025 Financial Results

    Company to host a conference call tomorrow, November 6, 2025, at 9:00 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. "Our third quarter results reflect strong execution on our core strategic priorities, with year-over-year growth in revenue, census and Adjusted EBITDA," said Barb Jacobsmeyer, president and CEO of Enhabit. "This progress allowed us to further reduce our bank debt and strengthen the balance sheet during the quarter." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $263.6 million Net income attributable to Enhabit, Inc. of $11.1 million

    11/5/25 4:13:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces Date of 2025 Third Quarter Earnings Call

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the third quarter ended Sept. 30, 2025, on Nov. 5, 2025, and host a webcast and conference call on Nov. 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 6, 2025 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/991714917 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospi

    10/16/25 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces CEO Transition Plan

    Barb Jacobsmeyer to Step Down; Board Commencing Thorough Search for Successor Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July 2026, or upon the appointment of a successor. The company has initiated a leadership succession plan with Jacobsmeyer's full support to ensure a smooth transition. The board has retained Russell Reynolds Associates, a leading executive search firm, to assist in a comprehensive search process to identify the company's next CEO. "I am honored to have served as the first CEO of Enhabit and to have be

    8/6/25 4:16:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care